These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11396175)
1. Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters. Nuyts S; Theys J; Landuyt W; van Mellaert L; Lambin P; Anné J Anticancer Res; 2001; 21(2A):857-61. PubMed ID: 11396175 [TBL] [Abstract][Full Text] [Related]
2. Clostridium as a tumor-specific delivery system of therapeutic proteins. Theys J; Landuyt AW; Nuyts S; Van Mellaert L; Lambin P; Anné J Cancer Detect Prev; 2001; 25(6):548-57. PubMed ID: 12132875 [TBL] [Abstract][Full Text] [Related]
3. Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation. Nuyts S; Van Mellaert L; Theys J; Landuyt W; Bosmans E; Anné J; Lambin P Gene Ther; 2001 Aug; 8(15):1197-201. PubMed ID: 11509951 [TBL] [Abstract][Full Text] [Related]
4. Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum. Theys J; Landuyt W; Nuyts S; Van Mellaert L; van Oosterom A; Lambin P; Anné J Cancer Gene Ther; 2001 Apr; 8(4):294-7. PubMed ID: 11393282 [TBL] [Abstract][Full Text] [Related]
5. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia. Fox ME; Lemmon MJ; Mauchline ML; Davis TO; Giaccia AJ; Minton NP; Brown JM Gene Ther; 1996 Feb; 3(2):173-8. PubMed ID: 8867865 [TBL] [Abstract][Full Text] [Related]
6. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis. Liu SC; Minton NP; Giaccia AJ; Brown JM Gene Ther; 2002 Feb; 9(4):291-6. PubMed ID: 11896468 [TBL] [Abstract][Full Text] [Related]
7. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor. Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281 [TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model. Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067 [TBL] [Abstract][Full Text] [Related]
9. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Lemmon MJ; van Zijl P; Fox ME; Mauchline ML; Giaccia AJ; Minton NP; Brown JM Gene Ther; 1997 Aug; 4(8):791-6. PubMed ID: 9338007 [TBL] [Abstract][Full Text] [Related]
10. Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium. Mei S; Theys J; Landuyt W; Anne J; Lambin P Anticancer Res; 2002; 22(6A):3261-6. PubMed ID: 12530073 [TBL] [Abstract][Full Text] [Related]
11. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene. Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328 [TBL] [Abstract][Full Text] [Related]
12. The use of radiation-induced bacterial promoters in anaerobic conditions: a means to control gene expression in clostridium-mediated therapy for cancer. Nuyts S; Van Mellaert L; Theys J; Landuyt W; Lambin P; Anné J Radiat Res; 2001 May; 155(5):716-23. PubMed ID: 11302769 [TBL] [Abstract][Full Text] [Related]
13. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001. Cunningham C; Nemunaitis J Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249 [TBL] [Abstract][Full Text] [Related]
14. [Hypoxia in malignant tumors the target for clostridial therapeutic gene strategies]. Wallner G; Misiuna P; Cygan W; Cygan Z Pol Merkur Lekarski; 2005 Aug; 19(110):242-4. PubMed ID: 16245444 [TBL] [Abstract][Full Text] [Related]
15. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532 [TBL] [Abstract][Full Text] [Related]
16. Clostridia in cancer therapy. Minton NP Nat Rev Microbiol; 2003 Dec; 1(3):237-42. PubMed ID: 15035028 [TBL] [Abstract][Full Text] [Related]
17. KDR promoter can transcriptionally target cytosine deaminase suicide gene to cancer cells of nonendothelial origin. Szary J; Kalita K; Przybyszewska M; Dus D; Kieda C; Janik P; Szala S Anticancer Res; 2001; 21(5):3471-5. PubMed ID: 11848511 [TBL] [Abstract][Full Text] [Related]
18. Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region. Hawkins LK; Johnson L; Bauzon M; Nye JA; Castro D; Kitzes GA; Young MD; Holt JK; Trown P; Hermiston TW Gene Ther; 2001 Aug; 8(15):1123-31. PubMed ID: 11509942 [TBL] [Abstract][Full Text] [Related]
19. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene. Pastorakova A; Hlubinova K; Altaner C Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715 [TBL] [Abstract][Full Text] [Related]